Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesSep 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 9, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 5, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 26, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 19, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJul 30, 2013View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionJul 29, 2013View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventJul 25, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 30, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 24, 2013View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerMay 23, 2013Download DOCDownload PDF
4/AAmendment to a previously filed 4May 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 23, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-153

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information